Genetic analysis of metabolic polymorphisms in molecular epidemiological studies: social and ethical implications.
The use of genetic biomarkers in epidemiological studies raises specific social and ethical issues related to the selection of molecular markers and methods of analysis, obtaining participation, the storage of biological samples and their linkage with individual data, the disclosure of information and the publication of results. Several of these issues are similar to those associated with the use of any type of biomarker in epidemiology. Other problems are specifically related to the use of genetic material and the perception that genetic information raises special concerns regarding privacy, risk of abuse and psychosocial impact in this chapter we define how genetic studies performed in the context of molecular epidemiological studies (genetic analysis) differ from genetic screening or genetic testing conducted in a clinical or public health context We then examine the ethical implications of this distinction and describe how general ethical principles may apply to genetic analysis in the area of molecular epidemiology. In particular we discuss specific questions such as those of obtaining participation, working with archival samples and communicating results. We advocate an approach whereby ethical issues are tackled as an intrinsic part of study design; this requires broad discussion with all the parties involved.
Hainaut
P
P
Unit of Mechanisms of Carcinogenesis, International Agency for Research on Cancer, Lyon, France.
Vähäkangas
K
K
D015415:Biomarkers; D015340:Epidemiologic Research Design; D004995:Ethics, Professional; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D006801:Humans; D008967:Molecular Biology; D017720:Molecular Epidemiology; D011110:Polymorphism, Genetic / Q000235:genetics*; D011640:Public Policy
D015415:Biomarkers